Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

INTRODUCTION: Patients at increased risk of bleeding and recurrent VTE who develop venous thromboembolism (VTE) present challenges for clinical management. This study evaluated the effectiveness and safety of apixaban vs warfarin in patients with VTE who have risk factors for bleeding or recurrences...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Hines, Dionne M., Lee, Theodore, Rosenblatt, Lisa, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070226/
https://www.ncbi.nlm.nih.gov/pubmed/36811795
http://dx.doi.org/10.1007/s12325-023-02440-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070226/
https://www.ncbi.nlm.nih.gov/pubmed/36811795
http://dx.doi.org/10.1007/s12325-023-02440-1

Ejemplares similares